Indeed, it has been demonstrated that CPT and CPT-11 induce activation of the NF-κB pathway in a variety of human carcinoma cell lines, a mechanism thought to contribute to resistance to chemotherapy [41,42,43]. Here, NFKB1 is linked to carcinoma.